Back

Microaxial flow pump or standard care in infarct-related cardiogenic shock: the DanGer shock trial

1 September 2024 (11:00 - 11:12)
Organised by: Logo
Congress Presentation Part of: The year in review: top trials in coronary interventions impacting guidelines and patient care Percutaneous Coronary Intervention (PCI) ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Christian Hassager

Rigshospitalet - Copenhagen University Hospital, Copenhagen (Denmark)

4 More presentations in this session

Presentation thumbnail
A placebo-controlled trial of percutaneous coronary intervention for stable angina: the ORBITA-2 trial
Doctor R. Al-Lamee (London, GB)
Slides Video
Presentation thumbnail
ILUMIEN IV: optical coherence tomography-guided vs. angiography-guided PCI
Doctor Z. Ali (Roslyn, US)
Slides Video
Presentation thumbnail
Paclitaxel-coated balloon vs. uncoated balloon for coronary in-stent restenosis: the AGENT IDE randomised clinical trial
Doctor R. Yeh (Boston, US)
Slides Video
Presentation thumbnail
The year in review: top trials in coronary interventions impacting guidelines and patient care - discussion
Video

Access the full session

Session thumbnail
The year in review: top trials in coronary interventions impacting guidelines and patient care
Video

The Event

Event poster

ESC Congress 2024

1 September 2024 11:00 CET
You may be interested in
thumbnail
Congress Presentation
Mechanical support devices in STEMI and shock: when and in whom?
thumbnail
Congress Presentation
Mechanical circulatory support is of benefit in cardiogenic shock: pro
thumbnail
Congress Presentation
Mechanical circulatory support is of benefit in cardiogenic shock: con

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources